Dendritic Cell Vaccine Effective in Early-stage Breast Cancer

News   Jan 05, 2017 | Moffitt Cancer Center

 
Dendritic Cell Vaccine Effective in Early-stage Breast Cancer
 
 
 

RELATED ARTICLES

Mouse Model of Human Immune System Inadequate for Stem Cell Studies

News

“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell studies, say Stanford researchers. Optimized models are needed for clinical decision-making.

READ MORE

Blood Test Predicts Prostate Tumor Resistance

News

A new blood test developed by researchers at the Technical University of Munich (TUM) can predict drug resistance in patients with advanced prostate cancer.

READ MORE

New Test for Rare Immunodeficiency

News

Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE